Scopolamine Produces Larger Antidepressant and Antianxiety Effects in Women Than in Men
Authors:
- 25 August 2010
- journal article
- research article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 35 (12) , 2479-2488
Abstract
Some antidepressant agents generate differential benefit based on gender. Blocking cholinergic muscarinic receptors using scopolamine produces robust and rapid antidepressant effects in males and females combined. This study evaluated if males and females differ in the antidepressant response magnitude following scopolamine administration. A total of 52 male and female outpatients meeting criteria for recurrent major depressive or bipolar disorder participated in a double-blind, randomized, placebo-controlled, crossover clinical trial involving seven i.v. infusions of placebo or scopolamine (4 μg/kg). Following a single-blind placebo lead-in, participants entered either a placebo-block/scopolamine-block or a scopolamine-block/placebo-block sequence. Each block included three sessions. Clinical ratings were acquired before each infusion and included the Montgomery–Asberg Depression Rating Scale (MADRS) and the Hamilton Anxiety Rating Scale (HAM-A). A treatment group × block interaction (F=21.0, pp=0.006). The treatment group × block interaction was also significant in males (F=3.8, p=0.043) and females (F=35.6, pp=0.009) indicated that the response magnitude was larger in women. The treatment × block interaction was significant for the HAM-A across gender (F=12.0, ppp=0.30). When comparing the baseline block to study end, the block × gender interaction (F=12.6, p=0.001) showed that the antianxiety response was greater in women. Men and women show a rapid antidepressant response following scopolamine, but the magnitude of response is larger in women than in men.Keywords
This publication has 53 references indexed in Scilit:
- Replication of Scopolamine's Antidepressant Efficacy in Major Depressive Disorder: A Randomized, Placebo-Controlled Clinical TrialBiological Psychiatry, 2010
- Estradiol and the relationship between dendritic spines, NR2B containing NMDA receptors, and the magnitude of long-term potentiation at hippocampal CA3–CA1 synapsesPsychoneuroendocrinology, 2009
- Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depressionBrain Structure and Function, 2008
- Antidepressant Efficacy of the Antimuscarinic Drug ScopolamineArchives of General Psychiatry, 2006
- Effects of raloxifene and estradiol on hippocampal acetylcholine release and spatial learning in the ratPsychoneuroendocrinology, 2004
- Glutamate and DepressionAnnals of the New York Academy of Sciences, 2003
- Gender Differences in Treatment Response to Sertraline Versus Imipramine in Chronic DepressionAmerican Journal of Psychiatry, 2000
- Women’s issues in mood disordersExpert Opinion on Pharmacotherapy, 2000
- Gonadal steroid modulation of neuroendocrine transduction: A transynaptic viewCellular and Molecular Neurobiology, 1996
- A Rating Scale for Mania: Reliability, Validity and SensitivityThe British Journal of Psychiatry, 1978